July 15, 2026 — RNews

#atrial fibrillation — Wednesday, July 15, 2026 (1 items)

hot top new

← prev day next day →

0

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial. (linkinghub.elsevier.com)

Sotomi Y … Sakata Y The Lancet 2026-07-15

#anticoagulation #atrial fibrillation #thrombosis #intervention #hemorrhage